BRIDGEWATER, N.J.--(BUSINESS WIRE)--Enzon Pharmaceuticals, Inc. (Nasdaq: ENZN) will be presenting Inhibition of HIF-1alpha antagonist from in vitro and in vivo studies on Sunday, April 13, at the 2008 American Association for Cancer Research (AACR) meeting in San Diego, California.
